Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Pietrantuono, Giuseppe  [Clear All Filters]
2024
Stathis A, Pirosa MCristina, Orsucci L, Feugier P, Tani M, Ghesquières H, Musuraca G, Rossi FGaia, Merli F, Guieze R, et al. IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma. Haematologica. 2024.
2023
Valvano L, Nozza F, D'Arena G, D'Auria F, De Luca L, Pietrantuono G, Mansueto G, Villani O, D'Agostino S, Lamorte D, et al. Preliminary analysis of double-negative T, double-positive T, and natural killer T-like cells in B-cell chronic lymphocytic leukemia. Cancer Med. 2023.
van de Donk NWCJ, Minnema MC, van der Holt B, Schjesvold F, Wu KLung, Broijl A, Roeloffzen WWH, Gadisseur A, Pietrantuono G, Pour L, et al. Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study. Lancet Oncol. 2023.
2019
Statuto T, Valvano L, Calice G, Villani O, Pietrantuono G, Mansueto G, D'Arena G, Vita G, Lalinga V, Possidente L, et al. Cytofluorimetric and immunohistochemical comparison for detecting bone marrow infiltration in non-Hodgkin lymphomas: a study of 354 patients. Leuk Res. 2019;88:106267.
2013
D'Arena G, Pietrantuono G, Buccino E, Pacifico G, Musto P. Fournier's Gangrene Complicating Hematologic Malignancies: a Case Report and Review of Licterature. Mediterr J Hematol Infect Dis. 2013;5(1):e2013067.